Skip to main content
Erschienen in: Annals of Surgical Oncology 10/2008

01.10.2008 | Gastrointestinal Oncology

Risk Factors Associated with Complication Following Laparoscopy-Assisted Gastrectomy for Gastric Cancer: A Large-Scale Korean Multicenter Study

verfasst von: Min Chan Kim, MD, Wook Kim, MD, Hyung Ho Kim, MD, Seung Wan Ryu, MD, Seong Yeob Ryu, MD, Kyo Young Song, MD, Hyuk Joon Lee, MD, Gyu Seok Cho, MD, Sang Uk Han, MD, Woo Jin Hyung, MD, Korean Laparoscopic Gastrointestinal Surgery Study (KLASS) Group

Erschienen in: Annals of Surgical Oncology | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of this multicenter retrospective study was to establish background data for future randomized clinical trial comparing open and laparoscopy-assisted gastrectomies (LAGs). We sought to evaluate the technical feasibility of LAG by determining the morbidity and mortality and identifying corresponding predictive factors.

Patients and Methods

A retrospective multicenter study was carried out in Korea on 1,485 patients in who, LAG had been attempted for gastric cancer under the care of ten surgeons, at ten institutions, during the period spanning May 1998 to December 2005. Patient characteristics, operative outcomes, and postoperative morbidities and mortalities were analyzed.

Results

Overall morbidity and mortality rates were 14.0% and 0.6%, respectively. Complications included: wound problem (4.2%, n = 62), intraluminal bleeding (1.3%, n = 20), intra-abdominal abscess or fluid collection (1.3%, n = 19), anastomotic leakage (1.3%, n = 18), and intra-abdominal bleeding (1.3%, n = 18). By using multivariate analysis we found that the two most important risk factors associated with postoperative complications were presence of comorbidity in the patient and lack of experience on the part of the surgeon.

Conclusion

LAG is a technically feasible, safe, and effective method for treating patients with gastric cancer. Extra caution in patients with comorbidities, and dedication to improving surgical proficiency in LAG, may decrease the risk of complications. Through this study, we have established the inclusion criteria for LAG. For our multicenter, prospective, randomized trials (NCT00452751), potential patients should have an American Society of Anesthesiology (ASA) score of less than 3, and surgeons performing the procedures should have experience with more than 50 cases of LAG.
Literatur
1.
Zurück zum Zitat Kappas AM, Fatouros M, Roukos DH. Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 2004; 11:727–30PubMedCrossRef Kappas AM, Fatouros M, Roukos DH. Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 2004; 11:727–30PubMedCrossRef
2.
Zurück zum Zitat Bonenkamp JJ, Songun I, Hermans J, et al. Radomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345:745–8PubMedCrossRef Bonenkamp JJ, Songun I, Hermans J, et al. Radomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345:745–8PubMedCrossRef
3.
Zurück zum Zitat Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet 1996; 347:995–9PubMedCrossRef Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet 1996; 347:995–9PubMedCrossRef
4.
Zurück zum Zitat Biffi R, Chiappa A, Luca F, et al. Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol 2006; 93:394–400PubMedCrossRef Biffi R, Chiappa A, Luca F, et al. Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol 2006; 93:394–400PubMedCrossRef
5.
Zurück zum Zitat Gil-Rendo A, Hernandez-Lizoain JL, Martinez-Regueira F, et al. Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer. Clin Trasl Oncol 2006; 8:354–61CrossRef Gil-Rendo A, Hernandez-Lizoain JL, Martinez-Regueira F, et al. Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer. Clin Trasl Oncol 2006; 8:354–61CrossRef
6.
Zurück zum Zitat Ohgami M, Otani Y, Kumai K, et al. Curative laparoscopic surgery for early gastric cancer: five years experience. World J Surg 1999; 23:187–92PubMedCrossRef Ohgami M, Otani Y, Kumai K, et al. Curative laparoscopic surgery for early gastric cancer: five years experience. World J Surg 1999; 23:187–92PubMedCrossRef
7.
Zurück zum Zitat Ohashi S. Laparoscopic intraluminal (intragastric) surgery for early gastric cancer. A new concept in laparoscopic surgery. Surg Endosc 1995; 9:169–71PubMedCrossRef Ohashi S. Laparoscopic intraluminal (intragastric) surgery for early gastric cancer. A new concept in laparoscopic surgery. Surg Endosc 1995; 9:169–71PubMedCrossRef
8.
Zurück zum Zitat Kitano S, Iso Y, Moriyama M, et al. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 1994; 4:146–8PubMed Kitano S, Iso Y, Moriyama M, et al. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 1994; 4:146–8PubMed
9.
Zurück zum Zitat Uyama I, Sugioka A, Fujita J, et al. Completely laparoscopic extragastric lymph node dissection for gastric malignancies located in the middle or lower third of the stomach. Gastric cancer 1999; 2:186–90PubMedCrossRef Uyama I, Sugioka A, Fujita J, et al. Completely laparoscopic extragastric lymph node dissection for gastric malignancies located in the middle or lower third of the stomach. Gastric cancer 1999; 2:186–90PubMedCrossRef
10.
Zurück zum Zitat Kim MC, Kim HH, Jung GJ. Surgical outcome of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer. Euro J Surg Oncol 2005; 31:401–5CrossRef Kim MC, Kim HH, Jung GJ. Surgical outcome of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer. Euro J Surg Oncol 2005; 31:401–5CrossRef
11.
Zurück zum Zitat Lee SI, Choi YS, Park DJ, et al. Comparative study of laparoscopy-assisted distal gastrectomy and open distal gastrectomy. J Am Coll Surg 2006; 202:874–80PubMedCrossRef Lee SI, Choi YS, Park DJ, et al. Comparative study of laparoscopy-assisted distal gastrectomy and open distal gastrectomy. J Am Coll Surg 2006; 202:874–80PubMedCrossRef
12.
Zurück zum Zitat Tanimura H, Higashino M, Fukunaga Y, et al. Laparoscopic distal gastrectomy with regional lymph node dissection for gastric cancer. Surg Endosc 2003; 17:758–62PubMedCrossRef Tanimura H, Higashino M, Fukunaga Y, et al. Laparoscopic distal gastrectomy with regional lymph node dissection for gastric cancer. Surg Endosc 2003; 17:758–62PubMedCrossRef
13.
Zurück zum Zitat Kim MC, Kim KH, Kim HH, et al. Comparison of laparoscopy-assisted by conventional open distal gastrectomy and extraperigastric lymph node dissection in early gastric cancer. J Surg Oncol 2005; 91:90–4. PubMedCrossRef Kim MC, Kim KH, Kim HH, et al. Comparison of laparoscopy-assisted by conventional open distal gastrectomy and extraperigastric lymph node dissection in early gastric cancer. J Surg Oncol 2005; 91:90–4. PubMedCrossRef
14.
Zurück zum Zitat Kitano S, Shiraishi N, Kakisako K, et al. Laparoscopy-assisted Billroth-I gastrectomy (LADG) for Cancer: our 10 years’ experience. Surg Laparosc Endosc Percutan Tech 2002; 12:204–7PubMedCrossRef Kitano S, Shiraishi N, Kakisako K, et al. Laparoscopy-assisted Billroth-I gastrectomy (LADG) for Cancer: our 10 years’ experience. Surg Laparosc Endosc Percutan Tech 2002; 12:204–7PubMedCrossRef
15.
Zurück zum Zitat Kim MC, Jung GJ, Kim HH. Morbidity and mortality of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer. Dig Dis Sci 2007; 52:543–8PubMedCrossRef Kim MC, Jung GJ, Kim HH. Morbidity and mortality of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer. Dig Dis Sci 2007; 52:543–8PubMedCrossRef
16.
Zurück zum Zitat Fujiwara M, Kodera Y, Kasai Y, et al. Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma: a review of 43 cases. J Am Coll Surg 2003; 196:75–81PubMedCrossRef Fujiwara M, Kodera Y, Kasai Y, et al. Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma: a review of 43 cases. J Am Coll Surg 2003; 196:75–81PubMedCrossRef
17.
Zurück zum Zitat Huscher CG, Mingoli A, Sgarzini G, et al. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg 2005; 241:232–7PubMedCrossRef Huscher CG, Mingoli A, Sgarzini G, et al. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg 2005; 241:232–7PubMedCrossRef
18.
Zurück zum Zitat Kitano S, Shiraishi N, Uyama I, et al. The Japanese laparoscopic surgery study group. A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg 2007; 245:68–72PubMedCrossRef Kitano S, Shiraishi N, Uyama I, et al. The Japanese laparoscopic surgery study group. A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg 2007; 245:68–72PubMedCrossRef
19.
Zurück zum Zitat Kim HH, Kim KH, Kim DH, et al. Nationwide survey of laparoscopic gastric surgery in Korea, 2004. J Korean Gastric Cancer Assoc 2005; 5:295–303 Kim HH, Kim KH, Kim DH, et al. Nationwide survey of laparoscopic gastric surgery in Korea, 2004. J Korean Gastric Cancer Assoc 2005; 5:295–303
20.
Zurück zum Zitat Macintyre IM, Akoh JA. Improving survival in gastric cancer: review of operative mortality in English language publications from 1970. Br J Surg 1991; 78:771–6PubMedCrossRef Macintyre IM, Akoh JA. Improving survival in gastric cancer: review of operative mortality in English language publications from 1970. Br J Surg 1991; 78:771–6PubMedCrossRef
21.
Zurück zum Zitat Kodera Y, Sasako M, Yamamoto S, et al. Gastric Cancer Surgery Study Group of Japan Clinical Oncology Group. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 2005; 92:1103–9PubMedCrossRef Kodera Y, Sasako M, Yamamoto S, et al. Gastric Cancer Surgery Study Group of Japan Clinical Oncology Group. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 2005; 92:1103–9PubMedCrossRef
22.
Zurück zum Zitat Park DJ, Lee HJ, Kim HH, et al. Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg 2005; 92:1099–102PubMedCrossRef Park DJ, Lee HJ, Kim HH, et al. Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg 2005; 92:1099–102PubMedCrossRef
23.
Zurück zum Zitat Alves A, Panis Y, Mathieu P, et al. Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study. Arch Surg 2005; 140:278–83PubMedCrossRef Alves A, Panis Y, Mathieu P, et al. Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study. Arch Surg 2005; 140:278–83PubMedCrossRef
24.
Zurück zum Zitat Jain NB, Guller U, Pietrobon R, et al. Comorbidities increase complication rates in patients having arthroplasty. Clin Orthop Relat Res 2005; 435:232–8PubMedCrossRef Jain NB, Guller U, Pietrobon R, et al. Comorbidities increase complication rates in patients having arthroplasty. Clin Orthop Relat Res 2005; 435:232–8PubMedCrossRef
25.
Zurück zum Zitat Ozalp N, Zulfikaroglu B, Bilgic I, et al. Evaluation of risk factors for mortality in perforated peptic ulcer in Ankara Numune Teaching Hospital, Ankara, Turkey. East Afr Med J 2004; 81:634–7PubMed Ozalp N, Zulfikaroglu B, Bilgic I, et al. Evaluation of risk factors for mortality in perforated peptic ulcer in Ankara Numune Teaching Hospital, Ankara, Turkey. East Afr Med J 2004; 81:634–7PubMed
26.
Zurück zum Zitat Kim MC, Jung GJ, Kim HH. Learning curve of laparoscopy-assisted distal gastrectomy with systemic lymphadenectomy for early gastric cancer. World J Gastroenterol 2005; 11:7508–11PubMed Kim MC, Jung GJ, Kim HH. Learning curve of laparoscopy-assisted distal gastrectomy with systemic lymphadenectomy for early gastric cancer. World J Gastroenterol 2005; 11:7508–11PubMed
27.
Zurück zum Zitat Hyung WJ, Song C, Cheong JH, et al. Factors influencing operation time of laparoscopy-assisted distal subtotal gastrectomy: analysis of consecutive 100 initial cases. Euro J Surg Oncol 2007; 33:314–9CrossRef Hyung WJ, Song C, Cheong JH, et al. Factors influencing operation time of laparoscopy-assisted distal subtotal gastrectomy: analysis of consecutive 100 initial cases. Euro J Surg Oncol 2007; 33:314–9CrossRef
28.
Zurück zum Zitat Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg 1997; 84:1567–71PubMedCrossRef Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg 1997; 84:1567–71PubMedCrossRef
29.
Zurück zum Zitat Pikarsky AJ, Saida Y, Yamaguchi T, et al. Is obesity a high-risk factor for laparoscopic colorectal surgery? Surg Endosc 2002; 16:855–8PubMedCrossRef Pikarsky AJ, Saida Y, Yamaguchi T, et al. Is obesity a high-risk factor for laparoscopic colorectal surgery? Surg Endosc 2002; 16:855–8PubMedCrossRef
30.
Zurück zum Zitat Kuczmarski RJ, Flegal KM, Campbell SM, et al. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 20(272):205–11CrossRef Kuczmarski RJ, Flegal KM, Campbell SM, et al. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 20(272):205–11CrossRef
Metadaten
Titel
Risk Factors Associated with Complication Following Laparoscopy-Assisted Gastrectomy for Gastric Cancer: A Large-Scale Korean Multicenter Study
verfasst von
Min Chan Kim, MD
Wook Kim, MD
Hyung Ho Kim, MD
Seung Wan Ryu, MD
Seong Yeob Ryu, MD
Kyo Young Song, MD
Hyuk Joon Lee, MD
Gyu Seok Cho, MD
Sang Uk Han, MD
Woo Jin Hyung, MD
Korean Laparoscopic Gastrointestinal Surgery Study (KLASS) Group
Publikationsdatum
01.10.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 10/2008
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0075-z

Weitere Artikel der Ausgabe 10/2008

Annals of Surgical Oncology 10/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.